
We asked experts, “What does the general public not understand about clinical trials?”

CancerNetwork spoke with multidisciplinary leaders in the cancer space regarding the recent chemotherapy drug shortages. These experts explained how treatment dosing needs to be adjusted to best conserve the supplies, and which cancers need to use cisplatin in the first line for curative intent.

Experts highlight their biggest takeaways and most important messages from the 24th Annual International Lung Cancer Congress.

Infection preventionists discuss the biggest challenges they face.

When treating a rare chronic disease like hemophilia, an integrative care approach is crucial for the best outcomes. As the practice expands, expert hematologists share the progress of integrative care has had for treating the chronic condition.

As the biosimilar market continues to grow, adoption and standardization is still unknown. Experts discuss what they expect and hope from the future of biosimilars.

During their time conducting on-site interviews on the floor at the American Headache Society Annual Scientific Meeting 2023, NeurologyLive asked experts in migraine and headache medicine on their insights based on hot topics presented in sessions during the meeting.

Experts highlight their biggest takeaways and most important data from the 2023 Kidney Cancer Research Summit.

Clinical trial investigators discuss interesting genitourinary cancer abstracts presented during the 2023 ASCO Annual Meeting in Chicago

Experts discuss the impact of antimicrobial resistance as a serious, global health problem, and offer some potential strategies to combat it.